Stockholm3 in a Multiethnic Cohort for Prostate Cancer Detection (SEPTA): A Prospective Multicentered Trial.
Hari T VigneswaranMartin EklundAndrea DiscacciatiTobias NordströmRebecca A HubbardNathan PerlisMichael R AbernDaniel M MoreiraScott E EggenerPaul YonoverAlexander K ChowKara WattsMichael A LissGregory R ThoresonAndre Luis AbreuGeoffrey A SonnThorgerdur PalsdottirAnna PlymFredrik WiklundHenrik GronbergBernice Oforinull nullPublished in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2024)
In a substantially diverse population, Stockholm3 significantly reduces unnecessary prostate biopsies while maintaining a similar sensitivity to PSA in detecting csPC.